Decreased incidence of prostate cancer with selenium supplementation: results of a double‐blind cancer prevention trial

Abstract

Although selenium shows no protective effects against the primary endpoint of squamous and basal cell carcinomas of the skin, the selenium-treated group had substantial reductions in the incidence of prostate cancer, and total cancer incidence and mortality that demand further evaluation in well-controlled prevention trials.